Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

rocketman2

Rank: Treasurer [?]

Points: 1977 [?]

Votes: 21 Score: 2.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith Email this morning

posted on Aug 17, 2021 08:33AM

Email from Zenith today regarding a positive article on a generic publication regarding breast cancer.

3 Recommendations

Re: Zenith Email this morning

KOO-KOO2

Aug 17, 2021 10:12AM

Re: Zenith Email this morning

KayakerBC

Aug 17, 2021 10:14AM

Re: Zenith Email this morning

fouremm

Aug 17, 2021 10:19AM

Re: Zenith Email this morning

Nextblockbuster

Aug 17, 2021 10:34AM

Re: Zenith Email this morning

KOO-KOO2

Aug 17, 2021 12:23PM

Re: Zenith Email this morning

fouremm

Aug 17, 2021 08:26PM

Re: Zenith Email this morning

Toinv

Aug 18, 2021 11:06AM

Re: Zenith Email this morning

Toinv

Aug 18, 2021 01:50PM